JACQULINE JANSEN: Open Payments
NPI 1801408547 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 85 payments from 21 companies in 2025. Trend: 2023 $1,767 · 2024 $1,173 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $159 |
| PFIZER INC. | 12 | $158 |
| ABBVIE INC. | 16 | $138 |
| Axsome Therapeutics, Inc. | 6 | $135 |
| Lilly USA, LLC | 6 | $101 |
| Novo Nordisk Inc | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Corcept Therapeutics | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
Products named: TRINTELLIX, Auvelity, REXULTI, MOUNJARO, QULIPTA, ELIQUIS, Korlym, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
